Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines.
Bloomberg | Bloomberg | Getty Images
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased